18889881171
Kalkine 0
countryflagUS
L

AAPL 177.7107 -5.6637% MSFT 352.845 -1.9439% NVDA 95.11 0.8483% GOOGL 144.665 -0.6422% GOOG 146.89 -0.5753% AMZN 170.9 -0.0585% META 507.57 0.5627% AVGO 150.01 2.5429% LLY 706.79 -4.2562% TSLA 226.7099 -5.3127% TSM 142.2964 -3.0678% V 307.425 -1.8219% JPM 210.3 0.0095% UNH 518.645 -1.2199% NVO 62.72 0.2718% WMT 82.66 -0.6371% LVMUY 110.78 -3.4176% XOM 101.01 -3.1915% LVMHF 558.69 -2.4974% MA 479.03 -2.1929%
AAPL 177.7107 -5.6637% MSFT 352.845 -1.9439% NVDA 95.11 0.8483% GOOGL 144.665 -0.6422% GOOG 146.89 -0.5753% AMZN 170.9 -0.0585% META 507.57 0.5627% AVGO 150.01 2.5429% LLY 706.79 -4.2562% TSLA 226.7099 -5.3127% TSM 142.2964 -3.0678% V 307.425 -1.8219% JPM 210.3 0.0095% UNH 518.645 -1.2199% NVO 62.72 0.2718% WMT 82.66 -0.6371% LVMUY 110.78 -3.4176% XOM 101.01 -3.1915% LVMHF 558.69 -2.4974% MA 479.03 -2.1929%

Home » Technical Analysis Reports » Kalkine Bearish Chart Report

Kalkine Bearish Chart Report

Erasca, Inc.

Apr 02, 2025

ERAS:NASDAQ
Investment Type
Small-Cap
Risk Level
Action
Rec. Price (US$)

Company Overview:

Erasca, Inc. (NASDAQ: ERAS) is a clinical-stage precision oncology company. The Company is focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. This Report covers the Action, Technical Indicators Analysis along with the Support Levels, Resistance Level, and Trend Indication on this one stock. Noted below is the illustrative bearish score based on technical indicators for the stock:

Xxxxxx Xxxxxx Xxxxxx

Xxxxxx Xxxxxx

Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .

Xxxxxx Xxxxxx Xxxxxx Xxxxxx & Xxxxxx

  • Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx
  • Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .

Xxxxxx Xxxxxx

Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .

Xxxxxx

Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .   

Interested?

Enter your details below and our team will help you to decide if this product is best for you.
  • Australia+61
  • Canada+1
  • India (भारत)+91
  • New Zealand+64
  • United Kingdom+44
  • United States+1
By submitting my details and clicking on the button below, I agree to Kalkine’s Terms and Conditions and Privacy Policy.
I agree to receive marketing calls from Kalkine on the phone number I have provided above. I understand and agree that these calls may be placed using an auto-dialer and that my consent is not a condition of any purchase.
Please wait processing your request...
Disclaimer-

Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions  and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.

Cogent Biosciences Inc

Cogent Biosciences…

  • Mar 26, 2025
  • Read Time :5 min
Microvast Holdings Inc

Microvast Holdings…

  • Mar 19, 2025
  • Read Time :10 Mins
Scholastic Corp

Scholastic Corpora…

  • Mar 12, 2025
  • Read Time :10 Mins
Capricor Therapeutics …

Capricor Therapeut…

  • Mar 05, 2025
  • Read Time :5 min
SAG Holdings Limited

SAG Holdings Limit…

  • Feb 26, 2025
  • Read Time :10 Mins